B
BeloorBayir Biotech
Bayir is professionally managed company enagaged in manufacture & marketing of select active Pharmaceuticals, Nutraceutical, and Botanical
About BeloorBayir Biotech
The story of BeloorBayir Biotech begins in 1981 in Bengaluru, India, when founder B.G. Bairy established a company focused on manufacturing and marketing active pharmaceutical ingredients and nutraceuticals. The core of the business was to create ingredients for products addressing health issues like obesity, diabetes, and heart disease. The company specialized in botanical extracts, sourcing from wild and pesticide-free plants to create natural medicines. For decades, the company grew steadily, building a reputation for its ingredients in international markets like the US, Europe, and Japan. A significant turning point came in 2014 when BeloorBayir secured a major funding round of 75 crore (approximately $12.4 million) from the India Agribusiness Fund. This investment was earmarked for expanding manufacturing capacity, enhancing research and development, and strengthening its presence in foreign markets. Following this, the company raised another $2.45 million in 2016, led by British International Investment. This infusion of capital allowed BeloorBayir, with B.G. Bairy's son Ajay Bairy as a director, to expand its ambitions. Plans were made to open a research and development facility in the United States to further build their brand and tap into the growing global market for supplements. Today, BeloorBayir operates as a public limited company, continuing to focus on its core of providing key ingredients to the pharmaceutical and nutraceutical industries worldwide.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Mar 2014 | $12M | $50M | Rabo Equity Advisors | — |
Growth signals
Latest recorded traffic for BeloorBayir Biotech is 230 monthly website visits, up 155.6% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
BeloorBayir Biotech in the Bengaluru ecosystem
The BeloorBayir Biotech office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
- RARabo Equity Advisors
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about BeloorBayir Biotech on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See BeloorBayir Biotech’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.




